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INTRODUCTION.
Primary hyperparathyroidism is a disease characterized by 
elevated serum calcium and inappropriately raised parathyroid 
hormone  (PTH)  levels.  Its  prevalence  is  3/1000  in  the 
general  population1.  Common  symptoms  include  fatigue, 
thirst, epigastric pain, renal colic and depression. 90% of 
cases are caused by single parathyroid adenomas and the 
treatment usually involves surgical excision of the abnormal 
gland. Inherited long QT syndrome (LQTS) is a disorder 
characterized by prolonged ventricular repolarisation and a 
propensity for syncope, polymorphic ventricular tachycardia 
(torsade de pointes), and sudden death2. The disease is now 
classified as a ‘channelopathy’, with mutations having been 
reported in genes encoding cardiac ion channels3. We report 
the case of a 40 year old woman with inherited LQTS who 
was  found  to  have  primary  hyperparathyroidism  and  her 
subsequent operative management.
CASE PRESENTATION
A  40  year  old  woman  was  diagnosed  with  LQTS  after 
attending the Cardiology Department of the Royal Victoria 
Hospital as part of family screening. Several relatives had 
been identified as carrying a mutation in the KCNQ1 gene. 
She reported no cardiac symptoms; in particular, she had no 
past history of syncope. However, she did note the recent 
onset of fatigue. There was no other past medical history 
of note and clinical examination was normal. Her resting 
electrocardiograph (ECG) revealed a QTc interval of 472msec 
(Fig  1). Ambulatory  ECG  monitoring  and  exercise  stress 
testing did not reveal any cardiac arrhythmias and she was 
commenced  prophylactically  on  low  dose  beta-blocker  to 
reduce her risk of fatal arrhythmias. Subsequent DNA analysis 
confirmed that she carried the same KCNQ1 mutation, which 
had been reported in other family members. Baseline serum 
electrolytes and thyroid function tests were normal, apart from 
an elevation in serum calcium of 3.3 mmol/litre [normal range 
2.10-2.60  mmol/litre].  Primary  hyperparathyroidism  was 
suspected. Serum parathyroid hormone (PTH) was 197pcg/ml 
(normal range 12-87 pcg/ml) and parathyroid pertechnetate 
MIBI  subtraction  scanning  showed  a  large  uptake  of 
radionuclide adjacent to the right lobe of the thyroid gland. 
A diagnosis of primary hyperparathyroidism was made and, 
in view of the marked persistent elevation of serum calcium, 
surgical intervention was recommended. Preoperatively, her 
levels of magnesium and potassium were optimised and ß 
blockade continued.
Anaesthesia  was  induced  with  target-controlled  infusion 
(TCI) of propofol, remifentanil and vecuronium with full 
monitoring and an arterial line in place. A very large right 
inferior  parathyroid  adenoma  was  identified  and  removed 
(Fig 2).
Postoperatively  calcium  and  magnesium  levels  and  QT 
interval  on  the  electrocardiogram  were  measured  daily. 
She was treated with prophylactic oral calcium to prevent a 
precipitous fall in calcium that may predispose to arrhythmia. 
Her serum calcium fell to the lower limit of normal and 
she was discharged home on postoperative day 5 without 
complication, to continue on oral calcium supplements in 
the short-term.
DISCUSSION
Inherited LQTS is characterised by a prolonged QT interval 
on ECG, and is caused by delayed myocyte repolarisation. 
It includes a group of disorders, known as channelopathies, 
which  result  from  mutations  in  genes  encoding  cardiac 
ion channels or ankyrin-B. Patients with this condition are 
predisposed  to  ventricular  tachyarrhythmias,  in  particular 
torsade de pointes, and can present with syncope or sudden 
death. In certain individuals the syncope may be related to 
increased emotion or exercise (adrenergic stimulation). To 
date, over 400 mutations have been reported in eight genes 
(LQT1-8)4. Seven of the eight genes code for ion-channel 
proteins (potassium / sodium / calcium) and the other gene 
encodes ankyrin-B, a membrane-anchoring protein associated 
with Na/K ATPase and the Na/Ca exchanger.  
Our patient had a mutation in the KCNQ1 gene (LQT1), 
the alpha unit of the slowly deactivating delayed rectifier 
potassium channel. This is one of the most common genes 
implicated  in  inherited  LQTS4.  In  normal  individuals 
ß-adrenoreceptor  stimulation  reduces  the  action  potential 
and  QT  interval;  however,  with  KCNQ1  gene  mutations © The Ulster Medical Society, 2007.
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the  channels  do  not  respond  normally,  thus  predisposing 
individuals  to  cardiac  arrhythmias.  Treatment  with 
ß-adrenoreceptor blocking medication can be very effective 
for these patients5. There are several acquired factors that have 
been shown to cause or worsen QT prolongation including 
hypomagnesaemia, hypokalaemia, and hypocalcaemia6. 
Primary  hyperparathyroidism  is  caused  by  adenomatous 
(87-90%)  or  hyperplastic  (5-12%)  parathyroid  gland  or 
glands releasing parathyroid hormone (PTH) autonomously. 
This  causes  serum  calcium  to  rise.  Following  successful 
surgery  PTH  levels  fall  to  within  the  normal  range  on 
day  one7. The  lowest  serum  calcium  levels  occur  around 
day  three  when  many  patients  may  become  temporarily 
(and  asymptomatically)  hypocalcaemic8.  Our  patient  was 
prophylactically treated with calcium to avoid a sharp drop 
in her serum calcium. 
Anaesthesia in patients with LQTS carries a risk of intra-
operative ventricular arrhythmias. Maintenance of normal 
serum  electrolyte  levels  is  important.   Alleviating  patient 
anxiety  and  maintaining  preoperative  normoxaemia, 
normocarbia and normoglycaemia all minimize sympathetic 
activation and may reduce this risk. However the anaesthetic 
team  should  be  prepared  to  manage  cardiac  arrhythmias, 
including torsade de pointes and ventricular fibrillation.
There  are  no  reported  cases  in  the  medical  literature  of 
primary  hyperparathyroidism  and  LQTS  co-segregating 
in the same patient. Postoperative hypocalcaemia that may 
occur following successful surgery and anaesthetic related 
adrenergic stimulation are risk factors for the development of 
ventricular arrhythmias in this rare cohort of patients. Careful 
perioperative  ß  blockade  and  electrolyte  management  are 
essential. Inhalation anaesthetic agents, such as isoflurane and 
sevoflurane, may prolong the QT interval in unpremedicated 
healthy  humans9.  However,  propofol  may  have  beneficial 
effects on the QT interval in patients with LQTS and was thus 
chosen as the anaesthetic agent of choice in this case.
CONCLUSION
LQTS is a rare condition predisposing to life-threatening 
ventricular arrhythmias. Its importance lies in the significant 
morbidity and mortality associated with a failure to recognize 
and treat it. Our case illustrates the steps that may be taken to 
minimize this risk in such patients in the perioperative period.   
These  steps  include  adequate  ß  blockade,  avoidance  of 
inhalation anaesthesia, careful attention to electrolyte balance 
and involvement and co-operation of a multidisciplinary team 
of specialists.
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Figure 1. Electrocardiograph showing lengthened QTc interval© The Ulster Medical Society, 2007.
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Figure 2. Large right inferior parathyroid adenoma in situ
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